Cargando…
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
New Delhi metallo-β-lactamase-1 (NDM-1) is capable of hydrolyzing nearly all β-lactam antibiotics, posing an emerging threat to public health. There are currently less effective treatment options for treating NDM-1 positive “superbug”, and no promising NDM-1 inhibitors were used in clinical practice...
Autores principales: | Zhao, Bing, Zhang, Xinhui, Yu, Tingting, Liu, Ying, Zhang, Xiaoling, Yao, Yongfang, Feng, Xuejian, Liu, Hongmin, Yu, Dequan, Ma, Liying, Qin, Shangshang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838035/ https://www.ncbi.nlm.nih.gov/pubmed/33532189 http://dx.doi.org/10.1016/j.apsb.2020.07.005 |
Ejemplares similares
-
Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1)
por: Shen, Bingzheng, et al.
Publicado: (2013) -
Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors
por: Shen, Bingzheng, et al.
Publicado: (2017) -
Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1)
por: Bibi, Zainab, et al.
Publicado: (2023) -
New metallo β-lactamase NDM-1
por: Raghunath, D.
Publicado: (2010) -
PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1
por: Li, Xiaohui, et al.
Publicado: (2023)